On August 27, JXR (01951) spent approximately HKD 5.9988 million to repurchase 2.627 million shares.
Jinxin Reproductive Medicine (01951) announced that on August 27, 2026, the company plans to spend approximately HKD 5.9988 million to repurchase 2.627 million shares, with a repurchase price ranging from HKD 2.245 to 2.35 per share.
JXR (01951) announced that on August 27, 2026, the company will spend approximately HKD 5.9988 million to repurchase 2.627 million shares, with a repurchase price of HKD 2.245 to 2.35 per share.
Related Articles
C TRANSMISSION (00658) released its interim results, with a net profit attributable to shareholders of 32.936 million yuan, marking a year-on-year turnaround from losses to profits.
ROYALE HOME (01198) announced its interim results, reporting a loss attributable to shareholders of 333 million yuan, an increase of 24.1% year-on-year.
On August 27, TUHU-W (09690) spent approximately HKD 3.4489 million to repurchase 283,400 shares.
C TRANSMISSION (00658) released its interim results, with a net profit attributable to shareholders of 32.936 million yuan, marking a year-on-year turnaround from losses to profits.
ROYALE HOME (01198) announced its interim results, reporting a loss attributable to shareholders of 333 million yuan, an increase of 24.1% year-on-year.
On August 27, TUHU-W (09690) spent approximately HKD 3.4489 million to repurchase 283,400 shares.
RECOMMEND
